Prednisolone does not reduce withdrawal headache: A randomized, double-blind study

Neurology

Volumn 69, Issue 1, 2007, Pages 26-31

  Bøe, Magne G ^a,f   Mygland, Åse ^a,b,c   Salvesen, Rolf ^d,e  

^a Sørlandet Hospital   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d NORDLAND HOSPITAL   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

^f SØRLANDET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; LEVOMEPROMAZINE; METOCLOPRAMIDE; PLACEBO; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIGRAINE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TENSION HEADACHE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 34347385386     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000263652.46222.e8     Document Type: Article

References (22)

1. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 (suppl 1):9-160.
2. Silberstein SD, Welch KM. Painkiller headache. Neurology 2002;59:972-974.
3. Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000;20:658-662.
4. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475-483.
5. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107-113.
6. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 2001;179:540-544.
7. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:69-77.
8. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
9. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine: Effectiveness and relationship of antimigraine and antidepressant effects. Neurology 1976;26:121-127.
10. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979;36:695-699.
11. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003;23:982-993.
12. Rossi P, Di LC, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006;26:1097-1105.
13. Trucco M, Meineri P, Ruiz L. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 2005;6:334-337.
14. Olesen J. The international classification of headache disorders: 2nd edition (ICHD-II). Rev Neurol (Paris) 2005;161:689-691.
15. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-746.
16. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004;62:1540-1544.
17. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001;57:1694-1698.
18. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.
19. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001;21:980-986.
20. Limmroth V, Katsarava Z. Medication overuse headache. Curr Opin Neurol 2004;17:301-306.
21. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006;66:1894-1898.
22. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre: clinical characteristics and treatment outcomes. Cephalalgia 2004;24:483-490.